Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugenio Arteaga

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Revista Medica De Chile|April 11, 2017
[Menopause and cardiovascular risk]Eugenio Arteaga Urzúa
Revista Medica De Chile|July 26, 2003
[Diagnostic errors in primary hyperparathyroidism]Eugenio Arteaga, Gilberto González
Revista Medica De Chile|February 7, 2019
[Does menopause hormone therapy reduce the risk of chronic diseases?]Juan Enrique Blümel, Eugenio Arteaga
Revista Medica De Chile|November 25, 2017
[The risks of avoiding hormone replacement therapy during menopause]Juan Enrique Blümel, Eugenio Arteaga
Thyroid : Official Journal of the American Thyroid Association|December 14, 2004
Successful treatment of hyperthyroidism with amiodarone in a patient with propylthiouracil-induced acute hepatic failureFrancisca Brusco, Gilberto González, Néstor Soto, et al.
Revista Medica De Chile|February 1, 2011
[Adipose tissue as an endocrine modulator: hormonal changes associated with obesity]René Baudrand B, Eugenio Arteaga U, Manuel Moreno G
Revista Medica De Chile|April 29, 2017
[Benign intraperitoneal metastatic leiomyomatosis: A case report]Paz García, Juan Ignacio Errázuriz, Carlos Fernández, et al.
Menopause (New York, N.Y.)|March 11, 2003
Raloxifene is a better antioxidant of low-density lipoprotein than estradiol or tamoxifen in postmenopausal women in vitroEugenio Arteaga, Paulina Villaseca, Marcelo Bianchi, et al.
Revista Medica De Chile|July 20, 2022
[Risk factors for the development of osteoarthritis in middle-aged women]Juan E Blümel, Sócrates Aedo, Eugenio Arteaga, et al.
Revista Medica De Chile|May 26, 2015
[Cervical macroadenoma causing hyperparathyroidism: Report of one case]Antonio Zapata P, José Delgado F, Gilberto González V, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Revista Medica De Chile|April 11, 2017
[Menopause and cardiovascular risk]Eugenio Arteaga Urzúa
Revista Medica De Chile|July 26, 2003
[Diagnostic errors in primary hyperparathyroidism]Eugenio Arteaga, Gilberto González
Revista Medica De Chile|February 7, 2019
[Does menopause hormone therapy reduce the risk of chronic diseases?]Juan Enrique Blümel, Eugenio Arteaga
Revista Medica De Chile|November 25, 2017
[The risks of avoiding hormone replacement therapy during menopause]Juan Enrique Blümel, Eugenio Arteaga
Thyroid : Official Journal of the American Thyroid Association|December 14, 2004
Successful treatment of hyperthyroidism with amiodarone in a patient with propylthiouracil-induced acute hepatic failureFrancisca Brusco, Gilberto González, Néstor Soto, et al.
Revista Medica De Chile|February 1, 2011
[Adipose tissue as an endocrine modulator: hormonal changes associated with obesity]René Baudrand B, Eugenio Arteaga U, Manuel Moreno G
Revista Medica De Chile|April 29, 2017
[Benign intraperitoneal metastatic leiomyomatosis: A case report]Paz García, Juan Ignacio Errázuriz, Carlos Fernández, et al.
Menopause (New York, N.Y.)|March 11, 2003
Raloxifene is a better antioxidant of low-density lipoprotein than estradiol or tamoxifen in postmenopausal women in vitroEugenio Arteaga, Paulina Villaseca, Marcelo Bianchi, et al.
Revista Medica De Chile|July 20, 2022
[Risk factors for the development of osteoarthritis in middle-aged women]Juan E Blümel, Sócrates Aedo, Eugenio Arteaga, et al.
Revista Medica De Chile|May 26, 2015
[Cervical macroadenoma causing hyperparathyroidism: Report of one case]Antonio Zapata P, José Delgado F, Gilberto González V, et al.
Pageof 5